Search Results - "HÄGERSTRAND, D"
-
1
Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity
Published in Neuro-oncology advances (01-01-2020)“…Abstract Background Glioblastomas display a high level of intratumoral heterogeneity with regard to both genetic and histological features. Within single…”
Get full text
Journal Article -
2
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia
Published in Leukemia (2024)“…The NFKBIE gene, which encodes the NF-κB inhibitor IκBε, is mutated in 3–7% of patients with chronic lymphocytic leukemia (CLL). The most recurrent alteration…”
Get full text
Journal Article -
3
TRAF2 is an NF-κB-activating oncogene in epithelial cancers
Published in Oncogene (08-01-2015)“…Aberrant nuclear factor (NF)-κB activation is frequently observed in human cancers. Genome characterization efforts have identified genetic alterations in…”
Get full text
Journal Article -
4
Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
Published in Oncogene (10-08-2006)“…High-grade gliomas, including glioblastomas, are malignant brain tumors for which improved treatment is urgently needed. Genetic studies have demonstrated the…”
Get full text
Journal Article -
5
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
Published in Leukemia (2024)“…SF3B1 mutations are recurrent in chronic lymphocytic leukemia (CLL), particularly enriched in clinically aggressive stereotyped subset #2. To investigate their…”
Get full text
Journal Article -
6
The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells
Published in Cancer reports (01-05-2022)“…Background The epithelial cell adhesion molecule (EpCAM) is a type I transmembrane and glycosylated protein, which is overexpressed in many neoplasms. However,…”
Get full text
Journal Article -
7
PO-336 Identification of SOX2 and SFRP2 as opposing regulators of glioblastoma heterogeneous subtypes
Published in ESMO open (01-07-2018)“…IntroductionGlioblastomas display high levels of intra-tumour heterogeneity. It has recently been shown that individual glioblastomas may contain an…”
Get full text
Journal Article -
8
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
Published in Oncotarget (2016)“…PROX1 is a transcription factor with an essential role in embryonic development and determination of cell fate. In addition, PROX1 has been ascribed…”
Get full text
Journal Article -
9
Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
Published in Oncotarget (25-02-2020)“…[This corrects the article DOI: 10.18632/oncotarget.19404.]…”
Get full text
Journal Article -
10
Erratum: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1 (Oncotarget (2017) 8 (84671-84684) DOI: 10.18632/oncotarget.19404)
Published in Oncotarget (25-02-2020)“…This article has been corrected: The Funding information has been updated. The complete Funding list is shown below: FUNDING This work was supported by the…”
Get full text
Journal Article -
11
P1282: DISEASE‐SPECIFIC U1 SPLICEOSOMAL RNA MUTATIONS IN MATURE B‐CELL NEOPLASMS
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
12
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Published in Clinical cancer research (15-06-2019)“…Fibroblasts expressing the orphan chemokine CXCL14 have been previously shown to associate with poor breast cancer prognosis and promote cancer growth. This…”
Get full text
Journal Article Web Resource -
13
Astrocytes enhance glioblastoma growth
Published in Glia (01-02-2020)“…Glioblastoma (GBM) is a deadly disease with a need for deeper understanding and new therapeutic approaches. The microenvironment of glioblastoma has previously…”
Get full text
Journal Article -
14
SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
Published in Oncogene (12-08-2021)“…Intratumoral heterogeneity is a characteristic of glioblastomas that contain an intermixture of cell populations displaying different glioblastoma subtype gene…”
Get full text
Journal Article -
15
Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
Published in Scientific reports (14-06-2022)“…Glioblastoma is a highly aggressive brain tumor with poor patient prognosis. Treatment outcomes remain limited, partly due to intratumoral heterogeneity and…”
Get full text
Journal Article -
16
Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype
Published in Cancer research (Chicago, Ill.) (15-10-2018)“…The homeodomain transcription factor PROX1 has been linked to several cancer types, including gliomas, but its functions remain to be further elucidated. Here…”
Get full text
Journal Article -
17
Correction to: SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
Published in Oncogene (12-08-2021)Get full text
Journal Article -
18
Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
Published in Oncotarget (17-10-2017)“…Glioblastoma multiforme (GBM) is an aggressive form of brain cancer with poor prognosis. Cancer cells are characterized by a specific redox environment that…”
Get full text
Journal Article -
19
Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2011)“…Putative cancer stem cells have been identified in glioblastomas and are associated with radio- and chemo-resistance. Further knowledge about these cells is…”
Get full text
Journal Article -
20
TRAF2 is an NF-[kappa]B-activating oncogene in epithelial cancers
Published in Oncogene (08-01-2015)“…Aberrant nuclear factor (NF)-kB activation is frequently observed in human cancers. Genome characterization efforts have identied genetic alterations in…”
Get full text
Journal Article